Novel approach for the prevention of contrast nephropathy

Experimental and Toxicologic Pathology

Volumn 62, Issue 1, 2010, Pages 81-89

  Colbay, Mehmet ^a   Yuksel, Seref ^a   Uslan, Ihsan ^a   Acarturk, Gursel ^a   Karaman, Ozcan ^a   Bas, Orhan ^a   Mollaoglu, Hakan ^a   Yagmurca, Murat ^a   Ozen, Oguz Aslan ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Contrast medium; N acetylcystein; Nephropathy; Oxidant antioxidant status

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CAFFEIC ACID PHENETHYL ESTER; CONTRAST MEDIUM; CREATININE; DIATRIZOATE; MALONALDEHYDE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; INJURY SEVERITY; KIDNEY INJURY; KIDNEY STRUCTURE; MALE; MICROSCOPY; NONHUMAN; RAT; RENAL PROTECTION; SCORING SYSTEM; WATER DEPRIVATION;

ACETYLCYSTEINE; ANIMALS; CAFFEIC ACIDS; CATALASE; CONTRAST MEDIA; CREATININE; GLUTATHIONE PEROXIDASE; KIDNEY; MALE; MALONDIALDEHYDE; PHENYLETHYL ALCOHOL; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 71849109446     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.02.119     Document Type: Article

References (47)

1. Aebi H. Catalase. Methods of enzymatic analysis (1974), Academic Press, New York
2. Asif A., and Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44 (2004) 12-24
3. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
4. Babu E., Gopalakrishnan V.K., Sriganth I.N., Gopalakrishnan R., and Sakthisekaran D. Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144 (1995) 7-11
5. Briguori C., Tavano D., and Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis 45 (2003) 493-503
6. Conesa E.L., Valero F., Nadal J.C., Fenoy F.J., Lopez B., Arregui B., et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 281 (2001) R730-R737
7. Deray G., Baumelou B., Martinez F., Brillet G., and Jacobs C. Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney. Clin Nephrol 36 2 (1991) 93-96
8. Deray G., Dubois M., Martinez F., Baumelou B., Beaufils H., Bourbouze R., et al. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 10 6 (1990) 507-513
9. Durak I., Yurtarslan Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 214 (1993) 103-104
10. Durham J.D., Caputo C., Dokko J., Zaharakis T., Pahlavan M., Keltz J., et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62 (2002) 2202-2207
11. Fadillioglu E., Erdogan H., Sogut S., and Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol 23 (2003) 71-74
12. Fountaine H., Harnish P., Andrew E., and Grynne B. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol 3 Suppl. 3 (1996) S475-S484
13. Gazi S., Altun A., and Erdogan O. Contrast-induced nephropathy: preventive and protective effects of melatonin. J Pineal Res 41 (2006) 53-57
14. Heyman S.N., Goldfarb M., Shina A., Karmeli F., and Rosen S. N-acetylcysteine ameliorates renal microcirculation: studies in rats. Kidney Int 63 (2003) 634-641
15. Heyman S.N., Brezis M., Reubinoff C.A., Greenfeld Z., Lechene C., Epstein F.H., et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 82 (1988) 401-412
16. Heyman S.N., Rosen S., and Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 2 (1994) 153-157
17. Irmak M.K., Koltuksuz U., Kutlu N.O., Yagmurca M., Ozyurt H., Karaman A., et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 29 (2001) 190-193
18. Lameire N., Van Biesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
19. Lin J., and Bonventre J.V. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 14 (2005) 105-110
20. Lorusso V., Taroni P., Alvino S., and Spinazzi A. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol 36 6 (2001) 309-316
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
22. Mazzon E., Britti D., De Sarro A., Caputi A.P., and Cuzzocrea S. Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol 424 (2001) 75-83
23. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
24. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast media safety committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9 (1999) 1602-1613
25. Murphy S.W., Barrett B.J., and Parfrey P.S. Contrast nephropathy. J Am Soc Nephrol 11 (2000) 177-182
26. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
27. Ogeturk M., Kus I., Colakoglu N., Zararsiz I., Ilhan N., and Sarsilmaz M. Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol 97 (2005) 273-280
28. Oktem F., Ozguner F., Sulak O., Olgar S., Akturk O., Yilmaz H.R., and Altuntas I. Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol Cell Biochem 277 (2005) 109-115
29. Ozen S., Akyol O., Iraz M., Sogut S., Ozugurlu F., Ozyurt H., et al. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 24 (2004) 27-35
30. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
31. Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
32. Parlakpinar H., Tasdemir S., Polat A., Bay-Karabulut A., Vardi N., Ucar M., et al. Protective role of caffeic acid phenethyl ester (CAPE) on gentamicin-induced acute renal toxicity in rats. Toxicology 207 (2005) 169-177
33. Rabb H., Ramirez G., Saba S.R., Reynolds D., Xu J., Flavell R., et al. Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 271 (1996) F408-F413
34. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237-1242
35. Rudnick M.R., and Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med Suppl. 5 (2003) S28-S33
36. Seyon R.A., Jensen L.A., Ferguson I.A., and Williams R.G. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. Heart Lung 36 (2007) 195-204
37. Shaikh Z.A., Zaman K., Tang W., and Vu T. Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine. Toxicol Lett 104 (1999) 137-142
38. Singri N., Ahya S.N., and Levin M.L. Acute renal failure. JAMA 289 (2003) 747-751
39. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., Korshunova G.A., Sumbatyan N.V., and Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329 (1993) 21-24
40. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
41. Tariq M., Morais C., Sobki S., Al Sulaiman M., and Al Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14 (1999) 923-929
42. Tepel M., Aspelin P., and Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113 (2006) 1799-1806
43. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
44. Voeltz M.D., Nelson M.A., McDaniel M.C., and Manoukian S.V. The important properties of contrast media: focus on viscosity. J Invasive Cardiol 19 3 (2007) 1A-9A
45. Voghel G., Thorin-Trescases N., Farhat N., Mamarbachi A.M., Villeneuve L., Fortier A., et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 129 5 (2008) 261-270
46. Wasowicz W., Neve J., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39 (1993) 2522-2526
47. Yilmaz H.R., Uz E., Yucel N., Altuntas I., and Ozcelik N. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18 (2004) 234-238